Merrimack Pharmaceuticals Inc (MACK), MannKind Corporation (MNKD), Synta Pharmaceuticals Corp. (SNTA): Horrendous Health-Care Stocks This Week

Page 2 of 2

Getting past horrendous

Which of this week’s horrendous stocks could be most likely to rebound? I think MannKind Corporation (NASDAQ:MNKD) could see better days ahead.

In my view, there’s one primary catalyst that holds the most potential to ignite MannKind Corporation (NASDAQ:MNKD)’s stock: an announcement that the company has secured a big partner for its expected eventual commercialization of Afrezza. FDA approval could help, also, but my guess is that most observers already expect that to happen. Lining up a major partner, though, would indicate that MannKind is on its way to having a good shot at success.

The article 3 Horrendous Health-Care Stocks This Week originally appeared on Fool.com and is written by Keith Speights.

Fool contributor Keith Speights has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Page 2 of 2